1. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. (31st May 2019) Authors: Khoja, L; Atenafu, E G; Suciu, S; Leyvraz, S; Sato, T; Marshall, E; Keilholz, U; Zimmer, L; Patel, S P; Piperno-Neumann, S; Piulats, J; Kivelä, T T; Pfoehler, C; Bhatia, S; Huppert, P; Van Iersel, L B J; De Vries, I J M; Penel, N; Vogl, T; Cheng, T Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. (31st January 2019) Authors: Hamid, O; Robert, C; Daud, A; Hodi, F S; Hwu, W J; Kefford, R; Wolchok, J D; Hersey, P; Joseph, R; Weber, J S; Dronca, R; Mitchell, T C; Patnaik, A; Zarour, H M; Joshua, A M; Zhao, Q; Jensen, E; Ahsan, S; Ibrahim, N; Ribas, A Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Purchasing silence. (10th April 2018) Authors: Tannock, I F; Joshua, A M Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗